Medical Cannabis: Unique Insights. Successful Product Launches.

The medical cannabis market is one of the youngest segments in the German pharmaceutical sector. As a pioneer in this field of market research, we have been collecting and analyzing data since the German medical cannabis market opened in 2017. Our unique portfolio of market analyses, initial consulting for your market entry, and customized workshops for your product launch positions your brands and products for success right from the start.


Make the Right Decision. Or None at All.
 

We provide the foundation you need: top-tier data quality down to highly granular regional levels.

  • Tailor-made and flexible solutions
  • Ongoing product development and optimization in close collaboration with our clients
  • Prescription data at PZN level available since July 2021 for even more detailed and accurate analyses in the SHI market
  • Extrapolated private health insurance shares derived from a panel of over 7,000 reporting pharmacies
Simon Lisicki, Client Consultant New Therapies (Med. Cannabis) 
We have been experts in the medical cannabis market from day one and, with highly granular regional structures and intelligently linked data sources, deliver data quality at a very high level – giving you a clear edge in a highly dynamic market environment.

Simon Lisicki, Client Consultant New Therapies (Med. Cannabis) 

The reality of 64 million patients. Your future.
 

We believe the best way to plan your future offerings is with our Patient Insights. These are based on anonymized healthcare services data from more than 64 million patients, whose real-world care we have been capturing and analyzing since March 2020. This corresponds to around 77 percent of all statutory health insurance (SHI) patients in Germany. All results can be extrapolated to the overall SHI market. For this purpose, we use a data privacy–approved process for anonymized data collection via a trust center. 

With our Patient Insights, you can analyze by parameters such as:

  • Number of patients
  • Age and gender
  • Prior and co-medication
  • Therapy adherence

Tailored special analyses are also possible. We are happy to support and advise you on all questions related to patient-level insights.


Our Green Line Portfolio.
Your competitive edge in sales and marketing.

 

Drawing on our collaboration with numerous leading industry partners and our deep understanding of the market, we developed the Green Line: Analytics and solutions designed to move you a quantum leap forward. Patient insights, product launch and lifecycle, sales management and targeting – we give your sales and marketing the powerful boost they need. 

ODV national (SHI billing data by place of prescription)

Analyze the entire German prescription drug market and present customer-specific market segments separately by statutory and private health insurance shares.

ODV regional (SHI billing data by place of prescription) 

Work with regional sales volumes and revenue figures for prescriptions – based precisely on the SHI billing data from pharmacy billing centers.

SHI billing data 

Gain in-depth insights into monthly SHI billing data for prescriptions – broken down by substance, product, and trade-form prescriptions across 22 physician specialty groups.

National Pharma Information (NPI)

Incorporate monthly purchasing data for all prescription medical cannabis products from community pharmacies – to support the best decisions in pharmaceutical marketing.

Regional Pharma Information (RPI)

Analyze community pharmacy purchasing down to the local level – for a more targeted sales force, new market opportunities, and optimized regional marketing activities.

RVI (Regional SHI billing data)

Compare your own products and those of your competitors down to the level of physician specialty groups – for precise physician target-group selection and optimized regional marketing.

Medical Cannabis Market Report

The quarterly overview of overall developments in the medical cannabis market, based on our diverse data sources.

Pharmacy Targeting

Identify pharmacies with high and low potential to deploy your sales force efficiently and unlock new growth opportunities.

Territory Alignment     

Optimize potential, workload, and field force availability – for precisely tailored, high-performing territory structures.


Growing Strong: The German Medical Cannabis Market in 2023.

107manufacturers with medical cannabis sales
1.557medical cannabis PZNs with sales
11,4 tonsof cannabis flowers dispensed
More than 4.300 litersof medical cannabis extracts dispensed
30.000statutory health insurance (SHI) patients used dronabinol – the most widely used medical cannabis substance